COSCIENS Biopharma Inc. (CSCI : TSX)
Common Stock
$9.18
CAD
+0.48 (5.52%)
Last updated: 2026-10-07
Follow CSCI
CSCI
COSCIENS Biopharma Inc.
WealthAwesomePerformance
1 Day
+5.52%
1 Week
-0.76%
1 Month
+24.05%
YTD
+216.55%
Key Statistics
Market Cap
$9.15M
52W High
$14.80
52W Low
$3.30
P/E Ratio
-
50 Day MA
$7.74
200 Day MA
$18.40
Beta
1.80
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/7/2026 | $8.88 | $9.94 | $8.88 | $9.18 | $9.18 | 1,702 |
| 10/6/2026 | $8.76 | $8.76 | $8.70 | $8.70 | $8.70 | 1,603 |
| 10/5/2026 | $8.88 | $8.88 | $8.88 | $8.88 | $8.88 | 100 |
| 10/1/2026 | $9.10 | $9.10 | $8.75 | $8.75 | $8.75 | 732 |
| 9/29/2026 | $8.96 | $9.25 | $8.96 | $9.25 | $9.25 | 211 |
| 9/25/2026 | $8.50 | $10.00 | $8.40 | $8.60 | $8.60 | 3,803 |
| 9/24/2026 | $7.51 | $8.39 | $7.51 | $8.39 | $8.39 | 500 |
| 9/22/2026 | $7.58 | $8.20 | $7.58 | $8.00 | $8.00 | 2,343 |
| 9/21/2026 | $7.50 | $7.50 | $7.50 | $7.50 | $7.50 | 408 |
| 9/18/2026 | $7.60 | $7.60 | $7.60 | $7.60 | $7.60 | 100 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CSCI's historical volatility
30-Day Vol
62.5%
Annualized
90-Day Vol
335.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$10.97
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.74 | C$7.85 – C$12.09 |
| 60 trading days | C$10.34 | C$7.62 – C$14.03 |
| 90 trading days | C$10.97 | C$7.56 – C$15.94 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About COSCIENS Biopharma Inc.
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important biologically active components; and avenanthramides, a natural-based ingredients used to inflammation-based diseases for the cosmeceutical and pharmaceutical industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally active peptidomimetic small molecule that stimulates the secretion of growth hormone from the pituitary gland. In addition, it focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. The company sells its products through its distribution network. It has license agreements with Pharmanovia, Davimed GmbH, and NK MEDITECH Ltd, as well as Agriculture Canada, Canadian Government, and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.
Financials
- Revenue (TTM)
- $8.72M
- EBITDA
- $-5.21M
- Profit Margin
- 75.11%
- ROE (TTM)
- -52.83%
- EPS (Diluted)
- -5.69
- Book Value
- 19.92
🔄 Recent Splits
50-for-150
Jul 3, 2026
1-for-4
May 3, 2024
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About CSCI
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
CSCI.TO news timeline
15 articles covering CSCI.TO, most recent first
LatestWhy COSCIENS Biopharma Inc. stock plummeted yesterday
September 2026
August 2026
- What's Going On With COSCIENS Biopharma Inc. Stock Tuesday?
- Why COSCIENS Biopharma Inc. stock plummeted yesterday
- Why COSCIENS Biopharma Inc. stock is skyrocketing today
- CSCI Reports Earnings — What Canadian Investors Should Know
- Why COSCIENS Biopharma Inc. stock plummeted yesterday
- What's Going On With COSCIENS Biopharma Inc. Stock Wednesday?
- Why COSCIENS Biopharma Inc. stock is plummeting today
- Why COSCIENS Biopharma Inc. stock is rising today
- Why COSCIENS Biopharma Inc. stock is rising today